Literature DB >> 15963330

Adjunctive Corticosteroids in Adults with Bacterial Meningitis.

Diederik van de Beek1, Jan de Gans.   

Abstract

Bacterial meningitis is a complex disorder in which neurologic injury is caused, in part, by the causative organism and, in part, by the host's own inflammatory response. In studies of experimental bacterial meningitis, adjuvant treatment with corticosteroids, specifically dexamethasone, has beneficial effects. On the basis of these experimental studies, several clinical trials were undertaken to determine the effects of adjunctive corticosteroids in patients with bacterial meningitis. On the basis of overall benefit without detrimental effects by subgroup analysis, dexamethasone therapy should be initiated before or with the first dose of antibiotic and should be continued in most patients with community-acquired acute bacterial meningitis. For patients with a low suspicion of meningitis but an urgent need for antibiotics before cerebrospinal fluid can be obtained, we recommend initiation of treatment with dexamethasone, with discontinuation of dexamethasone therapy as soon as the diagnosis has been excluded.

Entities:  

Year:  2005        PMID: 15963330     DOI: 10.1007/s11908-005-0061-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  46 in total

Review 1.  Corticosteroid insufficiency in acutely ill patients.

Authors:  Mark S Cooper; Paul M Stewart
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

2.  Early treatment of meningococcal disease.

Authors:  H T Sørensen; J Møller-Petersen; H B Krarup; H Pedersen; H Hansen; H Hamburger
Journal:  BMJ       Date:  1992-09-26

3.  Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988.

Authors:  P B McIntyre; C S Berkey; S M King; U B Schaad; T Kilpi; G Y Kanra; C M Perez
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

4.  Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone.

Authors:  W M Scheld; R G Dacey; H R Winn; J E Welsh; J A Jane; M A Sande
Journal:  J Clin Invest       Date:  1980-08       Impact factor: 14.808

5.  Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications.

Authors:  R M Sapolsky; W A Pulsinelli
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

6.  Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial.

Authors:  E M Molyneux; A L Walsh; H Forsyth; M Tembo; J Mwenechanya; K Kayira; L Bwanaisa; A Njobvu; S Rogerson; G Malenga
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

Review 7.  Steroids in adults with acute bacterial meningitis: a systematic review.

Authors:  Diederik van de Beek; Jan de Gans; Peter McIntyre; Kameshwar Prasad
Journal:  Lancet Infect Dis       Date:  2004-03       Impact factor: 25.071

8.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

9.  Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen.

Authors:  G A Syrogiannopoulos; A N Lourida; M C Theodoridou; I G Pappas; G C Babilis; J J Economidis; D J Zoumboulakis; N G Beratis; N S Matsaniotis
Journal:  J Infect Dis       Date:  1994-04       Impact factor: 5.226

10.  Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.

Authors:  I Lutsar; I R Friedland; H S Jafri; L Wubbel; A Ahmed; M Trujillo; C C McCoig; G H McCracken
Journal:  J Antimicrob Chemother       Date:  2003-09-01       Impact factor: 5.790

View more
  2 in total

Review 1.  Dexamethasone in adults with community-acquired bacterial meningitis.

Authors:  Diederik van de Beek; Jan de Gans
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Adjunctive dexamethasone therapy in unconfirmed bacterial meningitis in resource limited settings: is it a risk worth taking?

Authors:  Esayas Kebede Gudina; Markos Tesfaye; Aynishet Adane; Kinfe Lemma; Tamiru Shibiru; Andreas Wieser; Hans-Walter Pfister; Matthias Klein
Journal:  BMC Neurol       Date:  2016-08-26       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.